4basebio UK Societas (GB:4BB) has released an update.
4basebio PLC has successfully completed a strategic investment worth £40 million, involving Elevage Medical Technologies and M&G Investment Management Limited, with the issuance of new shares and a secondary sale. This investment increases Elevage and M&G’s stake to 29.9% of the company, which will now trade on AIM. The company also announced changes to its board of directors, welcoming new members from Elevage and 2Invest AG.
For further insights into GB:4BB stock, check out TipRanks’ Stock Analysis page.
